Quetmolimab is a humanized anti-CX3CL1 is a chemokine with a modulating effect on chemotaxis and adhesion[1].
[1]. Blaess J, et al. Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Ther Adv Musculoskelet Dis. 2020 Dec 16;12:1759720X20959971.
















